Investigadores
Inicio
Investigadores
Centro de Genómica e Investigación Oncología (GENYO). Granada.
Terapia Génica
Inmunoterapia Celular (células CAR)
Desarrollos Tecnológicos y Terapéuticos
Francisco Martin Molina
Investigador principal
Grupo de Investigación: Centro de Genómica e Investigación Oncología (GENYO). Granada.
Juan Antonio MARCHAL CORRALES
Investigador principal
Grupo de Investigación: Centro de Genómica e Investigación Oncología (GENYO). Granada.
Ana Hinckley Boned
Investigador colaborador
Grupo de Investigación: Centro de Genómica e Investigación Oncología (GENYO). Granada.
Concha Herrera Arroyo
Investigador colaborador
Grupo de Investigación: Centro de Genómica e Investigación Oncología (GENYO). Granada.
Elena López Ruiz
Investigador colaborador
Grupo de Investigación: Centro de Genómica e Investigación Oncología (GENYO). Granada.
Francisco Javier Molina Estévez
Investigador colaborador
Grupo de Investigación: Centro de Genómica e Investigación Oncología (GENYO). Granada.
Gema Jiménez González
Investigador colaborador
Grupo de Investigación: Centro de Genómica e Investigación Oncología (GENYO). Granada.
Houria Boulaiz Tassi
Investigador colaborador
Grupo de Investigación: Centro de Genómica e Investigación Oncología (GENYO). Granada.
Iris Ramos Hernández
Investigador colaborador
Grupo de Investigación: Centro de Genómica e Investigación Oncología (GENYO). Granada.
María Dolores Carmona Luque
Investigador colaborador
Grupo de Investigación: Centro de Genómica e Investigación Oncología (GENYO). Granada.
PILAR MUÑOZ FERNÁNDEZ
Investigador colaborador
Grupo de Investigación: Centro de Genómica e Investigación Oncología (GENYO). Granada.
Chocarro-Wrona C., Pleguezuelos-Beltrán P., López de Andrés J., Antich C., de Vicente J., Jiménez G., Arias-Santiago S., Gálvez-Martín P., López-Ruiz E., Marchal J.A.. A bioactive three-layered skin substitute based on ECM components effectively promotes skin wound healing and regeneration. Materials Today Bio. April 2025. DOI: 10.1016/j.mtbio.2025.101592.
Impacto: 8.7. Cuartil: Q1
(1er decil)
Usseglio N., Andrés J.L.d., Marchal J.A., Moroni L., Nieto D.. Photochemical corneal cross-linking: Evaluating the potential of a hand-held biopen. Materials Today Bio. April 2025. DOI: 10.1016/j.mtbio.2025.101512.
Impacto: 8.7. Cuartil: Q1
(1er decil)
Cavazza A., Molina-Estévez F.J., Reyes Á.P., Ronco V., Naseem A., Malenšek Š., Pečan P., Santini A., Heredia P., Aguilar-González A., Boulaiz H., Ni Q., Cortijo-Gutierrez M., Pavlovic K., Herrera I., de la Cerda B., Garcia-Tenorio E.M., Richard E., Granados-Principal S., López-Márquez A., Köber M., Stojanovic M., Vidaković M., Santos-Garcia I., Blázquez L., Haughton E., Yan D., Sánchez-Martín R.M., Mazini L., Aseguinolaza G.G., Miccio A., Rio P., Desviat L.R., Gonçalves M.A.F.V., Peng L., Jiménez-Mallebrera C., Molina F.M., Gupta D., Lainšček D., Luo Y., Benabdellah K.. Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group. Molecular Therapy Nucleic Acids. 11 March 2025. DOI: 10.1016/j.omtn.2025.102457.
Impacto: 6.5. Cuartil: Q1
Blanco B., Palma R., Hurtado M., Jiménez G., Griñán-Lisón C., Melchor J., Marchal J.A., Gomez H., Rus G., Soler J.. Modeling low-intensity ultrasound mechanotherapy impact on growing cancer stem cells. Mathematics and Computers in Simulation. February 2025. DOI: 10.1016/j.matcom.2024.08.030.
Impacto: 4.4. Cuartil: Q1
(1er decil)
Galocha-León C., Antich C., Voltes-Martínez A., Marchal J.A., Mallandrich M., Halbaut L., Souto E.B., Gálvez-Martín P., Clares-Naveros B.. Human mesenchymal stromal cells-laden crosslinked hyaluronic acid-alginate bioink for 3D bioprinting applications in tissue engineering. Drug Delivery and Translational Research. January 2025. DOI: 10.1007/s13346-024-01596-9.
Impacto: 5.7. Cuartil: Q1
Justicia-Lirio P., Tristán-Manzano M., Maldonado-Pérez N., Barbero-Jiménez C., Cortijo-Gutiérrez M., Pavlovic K., Molina-Estevez F.J., Muñoz P., Hinckley-Boned A., Rodriguez-Madoz J.R., Prosper F., Griñán-Lison C., Navarro-Marchal S.A., Panisello C., Muñoz-Ballester J., González-Sierra P.A., Herrera C., Marchal J.A., Martín F.. First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B cell lymphomas. Molecular Therapy Nucleic Acids. 10 December 2024. DOI: 10.1016/j.omtn.2024.102308.
Impacto: 6.5. Cuartil: Q1
Blaya-Cánovas J.L., Griñán-Lisón C., Blancas I., Marchal J.A., Ramírez-Tortosa C., López-Tejada A., Benabdellah K., Cortijo-Gutiérrez M., Cano-Cortés M.V., Graván P., Navarro-Marchal S.A., Gómez-Morales J., Delgado-Almenta V., Calahorra J., Agudo-Lera M., Sagarzazu A., Rodríguez-González C.J., Gallart-Aragón T., Eich C., Sánchez-Martín R.M., Granados-Principal S.. Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy. Molecular Cancer. December 2024. DOI: 10.1186/s12943-024-01997-x.
Impacto: 27.7. Cuartil: Q1
(1er decil)
Etzi F., Griñán-Lisón C., Fenu G., González-Titos A., Pisano A., Farace C., Sabalic A., Picon-Ruiz M., Marchal J.A., Madeddu R.. The Role of miR-486-5p on CSCs Phenotypes in Colorectal Cancer. Cancers. December 2024. DOI: 10.3390/cancers16244237.
Impacto: 4.5. Cuartil: Q1
Lara-Navarro I.J., Jave-Suárez L.F., Marchal J.A., Jaloma-Cruz A.R.. CRISPR/Cas9 Edition of the F9 Gene in Human Mesenchymal Stem Cells for Hemophilia B Therapy. Life. December 2024. DOI: 10.3390/life14121640.
Impacto: 3.2. Cuartil: Q1
Fenu G., Griñán-Lisón C., Pisano A., González-Titos A., Farace C., Fiorito G., Etzi F., Perra T., Sabalic A., Toledo B., Perán M., Solinas M.G., Porcu A., Marchal J.A., Madeddu R.. Unveiling the microRNA landscape in pancreatic ductal adenocarcinoma patients and cancer cell models. BMC Cancer. December 2024. DOI: 10.1186/s12885-024-13007-w.
Impacto: 3.4. Cuartil: Q2
López de Andrés J., Rodríguez-Santana C., de Lara-Peña L., Jiménez G., Escames G., Marchal J.A.. A bioengineered tumor matrix-based scaffold for the evaluation of melatonin efficacy on head and neck squamous cancer stem cells. Materials Today Bio. December 2024. DOI: 10.1016/j.mtbio.2024.101246.
Impacto: 8.7. Cuartil: Q1
(1er decil)
Toledo B., Zhu Chen L., Paniagua-Sancho M., Marchal J.A., Perán M., Giovannetti E.. Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy. Journal of Hematology and Oncology. December 2024. DOI: 10.1186/s13045-024-01559-0.
Impacto: 29.5. Cuartil: Q1
(1er decil)
Galocha-León C., Antich C., Clares-Naveros B., Voltes-Martínez A., Marchal J.A., Gálvez-Martín P.. Design and Characterization of Biomimetic Hybrid Construct Based on Hyaluronic Acid and Alginate Bioink for Regeneration of Articular Cartilage. Pharmaceutics. November 2024. DOI: 10.3390/pharmaceutics16111422.
Impacto: 4.9. Cuartil: Q1
Zubiarrain-Laserna A., Martínez-Moreno D., López de Andrés J., de Lara-Peña L., Guaresti O., Zaldua A.M., Jiménez G., Marchal J.A.. Beyond stiffness: deciphering the role of viscoelasticity in cancer evolution and treatment response. Biofabrication. 1 October 2024. DOI: 10.1088/1758-5090/ad5705.
Impacto: 8.2. Cuartil: Q1
Conejo-García A., Jiménez-Martínez Y., Cámara R., Franco-Montalbán F., Peña-Martín J., Boulaiz H., Carrión M.D.. New substituted benzoxazine derivatives as potent inducers of membrane permeability and cell death. Bioorganic and Medicinal Chemistry. 1 September 2024. DOI: 10.1016/j.bmc.2024.117849.
Impacto: 3.3. Cuartil: Q1
Garcia-Moreno F.M., Ruiz-Espigares J., Gutiérrez-Naranjo M.A., Marchal J.A.. Using deep learning for predicting the dynamic evolution of breast cancer migration. Computers in Biology and Medicine. September 2024. DOI: 10.1016/j.compbiomed.2024.108890.
Impacto: 7.0. Cuartil: Q1
(1er decil)
Carrillo-Gálvez A.B., Zurita F., Guerra-Valverde J.A., Aguilar-González A., Abril-García D., Padial-Molina M., Olaechea A., Martín-Morales N., Martín F., Valle F.O., Moreno P.G.. NLRP3 and AIM2 inflammasomes expression is modified by LPS and titanium ions increasing the release of active IL-1β in alveolar bone-derived MSCs. Stem Cells Translational Medicine. August 2024. DOI: 10.1093/stcltm/szae042.
Impacto: 5.4. Cuartil: Q1
Chocarro-Wrona C., López de Andrés J., Rioboó-Legaspi P., Pleguezuelos-Beltrán P., Antich C., De Vicente J., Gálvez-Martín P., López-Ruiz E., Marchal J.A.. Design and evaluation of a bilayered dermal/hypodermal 3D model using a biomimetic hydrogel formulation. Biomedicine and Pharmacotherapy. August 2024. DOI: 10.1016/j.biopha.2024.117051.
Impacto: 6.9. Cuartil: Q1
(1er decil)
Ramos M.C., Crespo-Sueiro G., de Pedro N., Griñán-Lisón C., Díaz C., Pérez-Victoria I., González-Menéndez V., Castillo F., Pérez del Palacio J., Tormo J.R., Choquesillo-Lazarte D., Marchal J.A., Vicente F., Fernández-Godino R., Genilloud O., Reyes F.. Onychocolone A produced by the fungus Onychocola sp. targets cancer stem cells and stops pancreatic cancer progression by inhibiting MEK2-dependent cell signaling. Biomedicine and Pharmacotherapy. August 2024. DOI: 10.1016/j.biopha.2024.117018.
Impacto: 6.9. Cuartil: Q1
(1er decil)
Ballesteros-Ribelles A., Millán-López A., Carmona-Luque M., Herrera C.. Granulocyte Colony Stimulating Factor-Mobilized Peripheral Blood Mononuclear Cells: An Alternative Cellular Source for Chimeric Antigen Receptor Therapy. International Journal of Molecular Sciences. June 2024. DOI: 10.3390/ijms25115769.
Impacto: 4.9. Cuartil: Q1
Calahorra J., Blaya-Cánovas J.L., Castellini-Pérez O., Aparicio-Puerta E., Cives-Losada C., Marin J.J.G., Rementeria M., Cara F.E., López-Tejada A., Griñán-Lisón C., Aulicino F., Berger I., Marchal J.A., Delgado-Almenta V., Granados-Principal S.. Unlocking the effective alliance of β-lapachone and hydroxytyrosol against triple-negative breast cancer cells. Biomedicine and Pharmacotherapy. May 2024. DOI: 10.1016/j.biopha.2024.116439.
Impacto: 6.9. Cuartil: Q1
(1er decil)
Peña-Martín J., García-Ortega M.B., Palacios-Ferrer J.L., Díaz C., García M.Á., Boulaiz H., Valdivia J., Jurado J.M., Almazan-Fernandez F.M., Santiago S.A., Vicente F., del Val C., del Palacio J.P., Marchal J.A.. Identification of novel biomarkers in the early diagnosis of malignant melanoma by untargeted liquid chromatography coupled to high-resolution mass spectrometry-based metabolomics: a pilot study. British Journal of Dermatology. May 2024. DOI: 10.1093/bjd/ljae013.
Impacto: 11.0. Cuartil: Q1
(1er decil)
Carmona-Luque M., Ballesteros-Ribelles A., Millán-López A., Blanco A., Nogueras S., Herrera C.. The Effect of Cell Culture Passage on the Efficacy of Mesenchymal Stromal Cells as a Cell Therapy Treatment. Journal of Clinical Medicine. May 2024. DOI: 10.3390/jcm13092480.
Impacto: 3.0. Cuartil: Q1
Treves B., Sonnini E., La Russa R., Del Duca F., Ghamlouch A., De Matteis A., Trignano C., Marchal J.A., Carrillo E., Napoletano G., Maiese A.. Can Hemorrhagic Stroke Genetics Help Forensic Diagnosis in Pediatric Age (<5 Years Old)?. Genes. May 2024. DOI: 10.3390/genes15050618.
Impacto: 2.8. Cuartil: Q2
Graván P., Rojas S., Picchi D.F., Galisteo-González F., Horcajada P., Marchal J.A.. Towards a More Efficient Breast Cancer Therapy Using Active Human Cell Membrane-Coated Metal–Organic Frameworks. Nanomaterials. May 2024. DOI: 10.3390/nano14090784.
Impacto: 4.4. Cuartil: Q2
Graván P., Peña-Martín J., de Andrés J.L., Pedrosa M., Villegas-Montoya M., Galisteo-González F., Marchal J.A., Sánchez-Moreno P.. Exploring the Impact of Nanoparticle Stealth Coatings in Cancer Models: From PEGylation to Cell Membrane-Coating Nanotechnology. ACS Applied Materials and Interfaces. 17 January 2024. DOI: 10.1021/acsami.3c13948.
Impacto: 8.3. Cuartil: Q1
Rangel-Peláez C., Martínez-Gutiérrez L., Tristán-Manzano M., Callejas J.L., Ortego-Centeno N., Martín F., Martín J.. CD19 CAR-T cell therapy: a new dawn for autoimmune rheumatic diseases?. Frontiers in Immunology. 2024. DOI: 10.3389/fimmu.2024.1502712.
Impacto: 5.7. Cuartil: Q1
Pérez-Lloret M., Reidy E., Lozano-Pérez A.A., Marchal J.A., Lens P.N.L., Ryan A.E., Erxleben A.. Auranofin loaded silk fibroin nanoparticles for colorectal cancer treatment. Drug Delivery and Translational Research. 2024. DOI: 10.1007/s13346-024-01719-2.
Impacto: 5.7. Cuartil: Q1
Pavlovic K., Carmona-Luque M., Corsi G.I., Maldonado-Pérez N., Molina-Estevez F.J., Peralbo-Santaella E., Cortijo-Gutiérrez M., Justicia-Lirio P., Tristán-Manzano M., Ronco-Díaz V., Ballesteros-Ribelles A., Millán-López A., Heredia-Velázquez P., Fuster-García C., Cathomen T., Seemann S.E., Gorodkin J., Martin F., Herrera C., Benabdellah K.. Generating universal anti-CD19 CAR T cells with a defined memory phenotype by CRISPR/Cas9 editing and safety evaluation of the transcriptome. Frontiers in Immunology. 2024. DOI: 10.3389/fimmu.2024.1401683.
Impacto: 5.7. Cuartil: Q1
Boulaiz H.. Editorial: Development of nanotherapeutics with multi-functionalities for targeting cancer cells. Frontiers in Immunology. 2024. DOI: 10.3389/fimmu.2024.1380937.
Impacto: 5.7. Cuartil: Q1
Martínez-Moreno D., Callejas A., Jiménez G., Gálvez-Martín P., Rus G., Marchal J.A.. Induction and real-time ultrasonic monitoring of 3D cartilage-like tissue by a low shear stresses-based bioreactor. International Journal of Bioprinting. 2024. DOI: 10.36922/ijb.3389.
Impacto: 6.8. Cuartil: Q1
Toledo B., Deiana C., Scianò F., Brandi G., Marchal J.A., Perán M., Giovannetti E.. Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives. Expert Review of Clinical Pharmacology. 2024. DOI: 10.1080/17512433.2024.2319340.
Impacto: 3.6. Cuartil: Q2
De Lara-Peña L., Farace C., Pisano A., de Andrés J.L., Fenu G., Etzi F., Griñán-Lisón C., Marchal J.A., Madeddu R.. Mimicking the Tumor Niche: Methods for Isolation, Culture, and Characterization of Cancer Stem Cells and Multicellular Spheroids. Methods in Molecular Biology. 2024. DOI: 10.1007/978-1-0716-3730-2_11.
Cavazza A., Hendel A., Bak R.O., Rio P., Güell M., Lainšček D., Arechavala-Gomeza V., Peng L., Hapil F.Z., Harvey J., Ortega F.G., Gonzalez-Martinez C., Lederer C.W., Mikkelsen K., Gasiunas G., Kalter N., Gonçalves M.A.F.V., Petersen J., Garanto A., Montoliu L., Maresca M., Seemann S.E., Gorodkin J., Mazini L., Sanchez R., Rodriguez-Madoz J.R., Maldonado-Pérez N., Laura T., Schmueck-Henneresse M., Maccalli C., Grünewald J., Carmona G., Kachamakova-Trojanowska N., Miccio A., Martin F., Turchiano G., Cathomen T., Luo Y., Tsai S.Q., Benabdellah K.. Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi. Molecular Therapy Nucleic Acids. 12 December 2023. DOI: 10.1016/j.omtn.2023.102066.
Impacto: 6.5. Cuartil: Q1
González-Pedroza M.G., Benítez A.R.T., Navarro-Marchal S.A., Martínez-Martínez E., Marchal J.A., Boulaiz H., Morales-Luckie R.A.. Biogeneration of silver nanoparticles from Cuphea procumbens for biomedical and environmental applications. Scientific Reports. December 2023. DOI: 10.1038/s41598-022-26818-3.
Impacto: 3.8. Cuartil: Q1
Navarro-Marchal S.A., Martín-Contreras M., Castro-Santiago D., del Castillo-Santaella T., Graván P., Jódar-Reyes A.B., Marchal J.A., Peula-García J.M.. Effect of the Protein Corona Formation on Antibody Functionalized Liquid Lipid Nanocarriers. International Journal of Molecular Sciences. December 2023. DOI: 10.3390/ijms242316759.
Impacto: 4.9. Cuartil: Q1
Galocha-León C., Antich C., Voltes-Martínez A., Marchal J.A., Mallandrich M., Halbaut L., Rodríguez-Lagunas M.J., Souto E.B., Clares-Naveros B., Gálvez-Martín P.. Development and characterization of a poloxamer hydrogel composed of human mesenchymal stromal cells (hMSCs) for reepithelization of skin injuries. International Journal of Pharmaceutics. 25 November 2023. DOI: 10.1016/j.ijpharm.2023.123535.
Impacto: 5.3. Cuartil: Q1
Nogueras Pérez R., Heredia-Nicolás N., de Lara-Peña L., López de Andrés J., Marchal J.A., Jiménez G., Griñán-Lisón C.. Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis. International Journal of Molecular Sciences. November 2023. DOI: 10.3390/ijms242116010.
Impacto: 4.9. Cuartil: Q1
Torres-Mansilla A., Álvarez-Lloret P., Voltes-Martínez A., López-Ruiz E., Baldión P.A., Marchal J.A., Gómez-Morales J.. Apatite-coated outer layer eggshell membrane: A novel osteoinductive biohybrid composite for guided bone/tissue regeneration. Biomaterials Advances. November 2023. DOI: 10.1016/j.bioadv.2023.213605.
Impacto: 5.5. Cuartil: Q2
Jaccard A., Wyss T., Maldonado-Pérez N., Rath J.A., Bevilacqua A., Peng J.J., Lepez A., Von Gunten C., Franco F., Kao K.C., Camviel N., Martín F., Ghesquière B., Migliorini D., Arber C., Romero P., Ho P.C., Wenes M.. Reductive carboxylation epigenetically instructs T cell differentiation. Nature. 28 September 2023. DOI: 10.1038/s41586-023-06546-y.
Impacto: 50.5. Cuartil: Q1
(1er decil)
Martinez-Navajas G., Ceron-Hernandez J., Simon I., Lupiañez P., Diaz-McLynn S., Perales S., Modlich U., Guerrero J.A., Martin F., Sevivas T., Lozano M.L., Rivera J., Ramos-Mejia V., Tersteeg C., Real P.J.. Lentiviral gene therapy reverts GPIX expression and phenotype in Bernard-Soulier syndrome type C. Molecular Therapy Nucleic Acids. 12 September 2023. DOI: 10.1016/j.omtn.2023.06.008.
Impacto: 6.5. Cuartil: Q1
García-Ortega M.B., Aparicio E., Griñán-Lisón C., Jiménez G., López-Ruiz E., Palacios J.L., Ruiz-Alcalá G., Alba C., Martínez A., Boulaiz H., Perán M., Hackenberg M., Bragança J., Calado S.M., Marchal J.A., García M.Á.. Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant Melanoma. Cancers. July 2023. DOI: 10.3390/cancers15143666.
Impacto: 4.5. Cuartil: Q1
Aguilera-Garrido A., Graván P., Navarro-Marchal S.A., Medina-O'Donnell M., Parra A., Gálvez-Ruiz M.J., Marchal J.A., Galisteo-González F.. Maslinic acid solid lipid nanoparticles as hydrophobic anticancer drug carriers: Formulation, in vitro activity and in vivo biodistribution. Biomedicine and Pharmacotherapy. July 2023. DOI: 10.1016/j.biopha.2023.114828.
Impacto: 6.9. Cuartil: Q1
(1er decil)
Ruiz-Malagón A.J., Hidalgo-García L., Rodríguez-Sojo M.J., Molina-Tijeras J.A., García F., Diez-Echave P., Vezza T., Becerra P., Marchal J.A., Redondo-Cerezo E., Hausmann M., Rogler G., Garrido-Mesa J., Rodríguez-Cabezas M.E., Rodríguez-Nogales A., Gálvez J.. Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response. Biomedicine and Pharmacotherapy. July 2023. DOI: 10.1016/j.biopha.2023.114760.
Impacto: 6.9. Cuartil: Q1
(1er decil)
López de Andrés J., Ruiz-Toranzo M., Antich C., Chocarro-Wrona C., López-Ruíz E., Jiménez G., Marchal J.A.. Biofabrication of a tri-layered 3D-bioprinted CSC-based malignant melanoma model for personalized cancer treatment. Biofabrication. 1 July 2023. DOI: 10.1088/1758-5090/ac8dc6.
Impacto: 8.2. Cuartil: Q1
Quintero-Espinosa D.A., Sanchez-Hernandez S., Velez-Pardo C., Martin F., Jimenez-Del-Rio M.. LRRK2 Knockout Confers Resistance in HEK-293 Cells to Rotenone-Induced Oxidative Stress, Mitochondrial Damage, and Apoptosis. International Journal of Molecular Sciences. July 2023. DOI: 10.3390/ijms241310474.
Impacto: 4.9. Cuartil: Q1
Tristán-Manzano M., Maldonado-Pérez N., Justicia-Lirio P., Cortijo-Gutierréz M., Tristán-Ramos P., Blanco-Benítez C., Pavlovic K., Aguilar-González A., Muñoz P., Molina-Estevez F.J., Griesche V., Marchal J.A., Heras S.R., Benabdellah K., Martin F.. Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells. Molecular Therapy Nucleic Acids. 13 June 2023. DOI: 10.1016/j.omtn.2023.03.018.
Impacto: 6.5. Cuartil: Q1
Sánchez-Guijo F., Avendaño-Solá C., Badimón L., Bueren J.A., Canals J.M., Delgadillo J., Delgado J., Eguizábal C., Fernández-Santos M.E., García-Olmo D., González-Aseguinolaza G., Juan M., Martín F., Mata R., Montserrat N., Pérez-Martínez A., Pérez-Simón J.A., Prósper F., Urbano-Ispizua Á., Zapata A.G., Sureda A., Moraleda J.M.. Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV). Bone Marrow Transplantation. June 2023. DOI: 10.1038/s41409-023-01962-0.
Impacto: 4.5. Cuartil: Q1
Blanco-Martín T., Guzmán-Puche J., Riazzo C., Gasca-Santiyán M., Hernández-García M., Cantón R., Torre-Cisneros J., Herrera C., Martínez-Martínez L.. Phenotypic and Molecular Characterization of an Enterobacter ludwigii Clinical Isolate Carrying a Plasmid-Mediated bla<inf>IMI-6</inf> Gene. Microbiology Spectrum. May 2023. DOI: 10.1128/spectrum.04620-22.
Impacto: 3.7. Cuartil: Q2
Cuende N., Vilarrodona A., Vuelta E., Marazuela R., Herrera C., Querol S., Sánchez-Ibáñez J., Carmona M., Gayá A., Tort J., Hernández D., Domínguez-Gil B.. Addressing Risks Derived from the Commodification of Substances of Human Origin: A European Proposal Applicable Worldwide. Transplantation. 1 April 2023. DOI: 10.1097/TP.0000000000004527.
Impacto: 5.3. Cuartil: Q1
(1er decil)
Graván P., Aguilera-Garrido A., Marchal J.A., Navarro-Marchal S.A., Galisteo-González F.. Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment. Advances in Colloid and Interface Science. April 2023. DOI: 10.1016/j.cis.2023.102871.
Impacto: 15.9. Cuartil: Q1
(1er decil)
Valverde-Pozo J., Paredes J.M., Widmann T.J., Griñan-Lison C., Ceccarelli G., Gioiello A., Garcia-Rubiño M.E., Marchal J.A., Alvarez-Pez J.M., Talavera E.M.. Ratiometric Two-Photon Near-Infrared Probe to Detect DPP IV in Human Plasma, Living Cells, Human Tissues, and Whole Organisms Using Zebrafish. ACS Sensors. 24 March 2023. DOI: 10.1021/acssensors.2c02025.
Impacto: 8.2. Cuartil: Q1
(1er decil)
Torres-Mansilla A., Hincke M., Voltes A., López-Ruiz E., Baldión P.A., Marchal J.A., Álvarez-Lloret P., Gómez-Morales J.. Eggshell Membrane as a Biomaterial for Bone Regeneration. Polymers. March 2023. DOI: 10.3390/polym15061342.
Impacto: 4.7. Cuartil: Q1
Moniche F., Cabezas-Rodriguez J.A., Valverde R., Escudero-Martinez I., Lebrato-Hernandez L., Pardo-Galiana B., Ainz L., Medina-Rodriguez M., de la Torre J., Escamilla-Gomez V., Ortega-Quintanilla J., Zapata-Arriaza E., de Albóniga-Chindurza A., Mancha F., Gamero M.A., Perez S., Espinosa-Rosso R., Forero-Diaz L., Moya M., Piñero P., Calderón-Cabrera C., Nogueras S., Jimenez R., Martin V., Delgado F., Ochoa-Sepúlveda J.J., Quijano B., Mata R., Santos-González M., Carmona-Sanchez G., Herrera C., Gonzalez A., Montaner J.. Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trial. The Lancet Neurology. February 2023. DOI: 10.1016/S1474-4422(22)00526-9.
Impacto: 46.5. Cuartil: Q1
(1er decil)
Valverde-Pozo J., Paredes J.M., García-Rubiño M.E., Widmann T.J., Griñan-Lison C., Lobon-Moles S., Marchal J.A., Alvarez-Pez J.M., Talavera E.M.. New ICT-Based Ratiometric Two-Photon near Infrared Probe for Imaging Tyrosinase in Living Cells, Tissues, and Whole Organisms. Chemosensors. February 2023. DOI: 10.3390/chemosensors11020145.
Impacto: 3.7. Cuartil: Q1
Aparicio-Pérez C., Carmona M., Benabdellah K., Herrera C.. Failure of ALL recognition by CAR T cells: a review of CD 19-negative relapses after anti-CD 19 CAR-T treatment in B-ALL. Frontiers in Immunology. 2023. DOI: 10.3389/fimmu.2023.1165870.
Impacto: 5.7. Cuartil: Q1
Penack O., Peczynski C., Boreland W., Lemaitre J., Afanasyeva K., Kornblit B., Jurado M., Martinez C., Natale A., Pérez-Simón J.A., Brunello L., Avenoso D., Klein S., Ozkurt Z.N., Herrera C., Wichert S., Chiusolo P., Gavriilaki E., Basak G.W., Schoemans H., Koenecke C., Moiseev I., Peric Z.. ECP versus ruxolitinib in steroid-refractory acute GVHD – a retrospective study by the EBMT transplant complications working party. Frontiers in Immunology. 2023. DOI: 10.3389/fimmu.2023.1283034.
Impacto: 5.7. Cuartil: Q1
Carmona-Luque M.D., Gonzalez-Alvarez L., Guerrero Orriach J.L.. Identification of miRNAs as Biomarkers of Cardiac Protection in Non-Genetically Modified Primary Human Cardiomyocytes Exposed to Halogenated Hypnotics in an In Vitro Model of Transfection and Ischemia/Reperfusion: A New Model in Translational Anesthesia. Life. January 2023. DOI: 10.3390/life13010064.
Impacto: 3.2. Cuartil: Q1
Santoro N., Mooyaart J.E., Devillier R., Koc Y., Vydra J., Castagna L., Gülbas Z., Martin J.D., Araujo M.C., Kulagin A., Arat M., Arroyo C.H., Martelli M.P., Di Ianni M., Hoogenboom J.D., de Wreede L.C., Ruggeri A., Chabannon C.. Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party. Bone Marrow Transplantation. January 2023. DOI: 10.1038/s41409-022-01839-8.
Impacto: 4.5. Cuartil: Q1
Barungi S., Hernández-Camarero P., Moreno-Terribas G., Villalba-Montoro R., Marchal J.A., López-Ruiz E., Perán M.. Clinical implications of inflammation in atheroma formation and novel therapies in cardiovascular diseases. Frontiers in Cell and Developmental Biology. 2023. DOI: 10.3389/fcell.2023.1148768.
Impacto: 4.6. Cuartil: Q1
Diaz-Ruano A.B., Martinez-Alarcon N., Perán M., Benabdellah K., Garcia-Martinez M.d.l.Á., Preda O., Ramirez-Tortosa C., Gonzalez-Hernandez A., Marchal J.A., Picon-Ruiz M.. Estradiol and Estrone Have Different Biological Functions to Induce NF-κB-Driven Inflammation, EMT and Stemness in ER+ Cancer Cells. International Journal of Molecular Sciences. January 2023. DOI: 10.3390/ijms24021221.
Impacto: 4.9. Cuartil: Q1
López-Tejada A., Griñán-Lisón C., González-González A., Cara F.E., Luque R.J., Rosa-Garrido C., Blaya-Cánovas J.L., Navarro-Ocón A., Valenzuela-Torres M., Parra-López M., Calahorra J., Blancas I., Marchal J.A., Granados-Principal S.. TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression. International Journal of Biological Sciences. 2023. DOI: 10.7150/ijbs.78738.
Impacto: 8.2. Cuartil: Q1
Martin F., Schambach A., Maccalli C.. Editorial: Engineered immune cells in cancer immunotherapy (EICCI). Frontiers in Immunology. 20 December 2022. DOI: 10.3389/fimmu.2022.1119363.
Impacto: 7.3. Cuartil: Q1
Toledo B., Picon-Ruiz M., Marchal J.A., Perán M.. Dual Role of Fibroblasts Educated by Tumour in Cancer Behavior and Therapeutic Perspectives. International Journal of Molecular Sciences. December 2022. DOI: 10.3390/ijms232415576.
Impacto: 5.6. Cuartil: Q1
Maldonado-Pérez N., Tristán-Manzano M., Justicia-Lirio P., Martínez-Planes E., Muñoz P., Pavlovic K., Cortijo-Gutiérrez M., Blanco-Benítez C., Castella M., Juan M., Wenes M., Romero P., Molina-Estévez F.J., Marañón C., Herrera C., Benabdellah K., Martin F.. Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma. Frontiers in Immunology. 6 October 2022. DOI: 10.3389/fimmu.2022.1011858.
Impacto: 7.3. Cuartil: Q1
Martínez-Moreno D., Venegas-Bustos D., Rus G., Gálvez-Martín P., Jiménez G., Marchal J.A.. Chondro-Inductive b-TPUe-Based Functionalized Scaffolds for Application in Cartilage Tissue Engineering. Advanced Healthcare Materials. October 5, 2022. DOI: 10.1002/adhm.202200251.
Impacto: 10.0. Cuartil: Q1
(1er decil)
Pleguezuelos-Beltrán P., Gálvez-Martín P., Nieto-García D., Marchal J.A., López-Ruiz E.. Advances in spray products for skin regeneration. Bioactive Materials. October 2022. DOI: 10.1016/j.bioactmat.2022.02.023.
Ríos-Galacho M., Martínez-Moreno D., López-Ruiz E., Gálvez-Martín P., Marchal J.A.. An Overview on the Manufacturing of Functional and Mature Cellular Skin Substitutes. Tissue Engineering - Part B: Reviews. 1 October 2022. DOI: 10.1089/ten.teb.2021.0131.
Impacto: 6.4. Cuartil: Q1
Valle-Arroyo J., Páez-Vega A., Fernández-Moreno R., López-Jiménez J., Luna A., Duarte R., Serrano-Martínez F., Villar S., Fernández-Alonso M., Reina G., González-Rico C., Fariñas M.C., Rojas R., Herrera C., Martín C., García-Torres E., Torre-Cisneros J., Cantisán S.. Humoral/Cellular Immune Discordance in Stem Cell Donors: Impact on Cytomegalovirus-Specific Immune Reconstitution after Related Hematopoietic Transplantation. Transplantation and Cellular Therapy. October 2022. DOI: 10.1016/j.jtct.2022.07.005.
Impacto: 3.2. Cuartil: Q2
Tristán-Manzano M., Maldonado-Pérez N., Justicia-Lirio P., Muñoz P., Cortijo-Gutiérrez M., Pavlovic K., Jiménez-Moreno R., Nogueras S., Carmona M.D., Sánchez-Hernández S., Aguilar-González A., Castella M., Juan M., Marañón C., Marchal J.A., Benabdellah K., Herrera C., Martin F.. Erratum: Physiological lentiviral vectors for the generation of improved CAR-T cells (Molecular Therapy - Oncolytics (2022) 25 (335–349), (S2372770522000687), (10.1016/j.omto.2022.05.003)). Molecular Therapy Oncolytics. 15 September 2022. DOI: 10.1016/j.omto.2022.07.005.
Impacto: 5.7. Cuartil: Q2
Devillier R., Galimard J.E., Labopin M., Blaise D., Raiola A.M., Pavlu J., Castagna L., Socié G., Chalandon Y., Martino M., Stölzel F., Bug G., Bruno B., Vrhovac R., Charbonnier A., Olivieri A., Bay J.O., Arroyo H., Yakoub-Agha I., Avenoso D., Neubauer A., Nguyen S., Forcade E., Brissot E., Savani B., Nagler A., Mohty M.. Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT. Bone Marrow Transplantation. September 2022. DOI: 10.1038/s41409-022-01674-x.
Impacto: 4.8. Cuartil: Q1
Nieto D., Jiménez G., Moroni L., López-Ruiz E., Gálvez-Martín P., Marchal J.A.. Biofabrication approaches and regulatory framework of metastatic tumor-on-a-chip models for precision oncology. Medicinal Research Reviews. September 2022. DOI: 10.1002/med.21914.
Impacto: 13.3. Cuartil: Q1
(1er decil)
Tamayo-Angorrilla M., López de Andrés J., Jiménez G., Marchal J.A.. The biomimetic extracellular matrix: a therapeutic tool for breast cancer research. Translational Research. September 2022. DOI: 10.1016/j.trsl.2021.11.008.
Impacto: 7.8. Cuartil: Q1
(1er decil)
Aibar-Almazán A., Voltes-Martínez A., Castellote-Caballero Y., Afanador-Restrepo D.F., Carcelén-Fraile M.d.C., López-Ruiz E.. Current Status of the Diagnosis and Management of Osteoporosis. International Journal of Molecular Sciences. August 2022. DOI: 10.3390/ijms23169465.
Impacto: 5.6. Cuartil: Q1
Hernández-Camarero P., López-Ruiz E., Marchal J.A., Perán M.. Unifying Different Cancer Theories in a Unique Tumour Model: Chronic Inflammation and Deaminases as Meeting Points. International Journal of Molecular Sciences. August 2022. DOI: 10.3390/ijms23158720.
Impacto: 5.6. Cuartil: Q1
Gallardo A., Molina A., Asenjo H.G., Lopez-Onieva L., Martorell-Marugán J., Espinosa-Martinez M., Griñan-Lison C., Alvarez-Perez J.C., Cara F.E., Navarro-Marchal S.A., Carmona-Sáez P., Medina P.P., Marchal J.A., Granados-Principal S., Sánchez-Pozo A., Landeira D.. EZH2 endorses cell plasticity to non-small cell lung cancer cells facilitating mesenchymal to epithelial transition and tumour colonization. Oncogene. 8 July 2022. DOI: 10.1038/s41388-022-02375-x.
Impacto: 8.0. Cuartil: Q1
(1er decil)
Aparicio-Puerta E., Gómez-Martín C., Giannoukakos S., Medina J.M., Scheepbouwer C., García-Moreno A., Carmona-Saez P., Fromm B., Pegtel M., Keller A., Marchal J.A., Hackenberg M.. sRNAbench and sRNAtoolbox 2022 update: accurate miRNA and sncRNA profiling for model and non-model organisms. Nucleic Acids Research. 5 July 2022. DOI: 10.1093/nar/gkac363.
Impacto: 14.9. Cuartil: Q1
(1er decil)
Díaz C., González-Olmedo C., Díaz-Beltrán L., Camacho J., Mena García P., Martín-Blázquez A., Fernández-Navarro M., Ortega-Granados A.L., Gálvez-Montosa F., Marchal J.A., Vicente F., Pérez del Palacio J., Sánchez-Rovira P.. Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: a novel metabolomics approach. Molecular Oncology. July 2022. DOI: 10.1002/1878-0261.13216.
Impacto: 6.6. Cuartil: Q1
Cueto-Ureña C., Mocholí E., Escrivá-Fernández J., González-Granero S., Sánchez-Hernández S., Solana-Orts A., Ballester-Lurbe B., Benabdellah K., Guasch R.M., García-Verdugo J.M., Martín F., Coffer P.J., Pérez-Roger I., Poch E.. Rnd3 Expression is Necessary to Maintain Mitochondrial Homeostasis but Dispensable for Autophagy. Frontiers in Cell and Developmental Biology. 27 June 2022. DOI: 10.3389/fcell.2022.834561.
Impacto: 5.5. Cuartil: Q1
Tristán-Manzano M., Maldonado-Pérez N., Justicia-Lirio P., Muñoz P., Cortijo-Gutiérrez M., Pavlovic K., Jiménez-Moreno R., Nogueras S., Carmona M.D., Sánchez-Hernández S., Aguilar-González A., Castella M., Juan M., Marañón C., Marchal J.A., Benabdellah K., Herrera C., Martin F.. Physiological lentiviral vectors for the generation of improved CAR-T cells. Molecular Therapy Oncolytics. 16 June 2022. DOI: 10.1016/j.omto.2022.05.003.
Impacto: 5.7. Cuartil: Q2
Domingo-Reinés J., Martínez-Navajas G., Montes R., Lamolda M., Simón I., Castaño J., Ríos-Pelegrina R., Lopez-Hidalgo J.L., García del Moral R., Marchal J.A., Real P.J., Ramos-Mejía V.. Generation of a H9 Clonal Cell Line With Inducible Expression of NUP98-KDM5A Fusion Gene in the AAVS1 Safe Harbor Locus. Frontiers in Cell and Developmental Biology. 1 June 2022. DOI: 10.3389/fcell.2022.846092.
Impacto: 5.5. Cuartil: Q1
Aguilar-González A., González-Correa J.E., Barriocanal-Casado E., Ramos-Hernández I., Lerma-Juárez M.A., Greco S., Rodríguez-Sevilla J.J., Molina-Estévez F.J., Montalvo-Romeral V., Ronzitti G., Sánchez-Martín R.M., Martín F., Muñoz P.. Isogenic GAA-KO Murine Muscle Cell Lines Mimicking Severe Pompe Mutations as Preclinical Models for the Screening of Potential Gene Therapy Strategies. International Journal of Molecular Sciences. June-1 2022. DOI: 10.3390/ijms23116298.
Impacto: 5.6. Cuartil: Q1
Wenes M., Jaccard A., Wyss T., Maldonado-Pérez N., Teoh S.T., Lepez A., Renaud F., Franco F., Waridel P., Yacoub Maroun C., Tschumi B., Dumauthioz N., Zhang L., Donda A., Martín F., Migliorini D., Lunt S.Y., Ho P.C., Romero P.. The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function. Cell Metabolism. 3 May 2022. DOI: 10.1016/j.cmet.2022.03.013.
Impacto: 29.0. Cuartil: Q1
(1er decil)
Murtazina A., Alcala G.R., Jimenez-Martinez Y., Marchal J.A., Tarabayeva A., Bitanova E., McDougall G., Bishimbayeva N., Boulaiz H.. Anti-Cancerous Potential of Polysaccharides Derived from Wheat Cell Culture. Pharmaceutics. May 2022. DOI: 10.3390/pharmaceutics14051100.
Impacto: 5.4. Cuartil: Q1
Gómez-Morales J., Fernández-Penas R., Acebedo-Martínez F.J., Romero-Castillo I., Verdugo-Escamilla C., Choquesillo-Lazarte D., Esposti L.D., Jiménez-Martínez Y., Fernández-Sánchez J.F., Iafisco M., Boulaiz H.. Luminescent Citrate-Functionalized Terbium-Substituted Carbonated Apatite Nanomaterials: Structural Aspects, Sensitized Luminescence, Cytocompatibility, and Cell Uptake Imaging. Nanomaterials. April-2 2022. DOI: 10.3390/nano12081257.
Lafuente-Merchan M., Ruiz-Alonso S., Zabala A., Gálvez-Martín P., Marchal J.A., Vázquez-Lasa B., Gallego I., Saenz-del-Burgo L., Pedraz J.L.. Chondroitin and Dermatan Sulfate Bioinks for 3D Bioprinting and Cartilage Regeneration. Macromolecular Bioscience. March 2022. DOI: 10.1002/mabi.202100435.
Impacto: 4.6. Cuartil: Q1
Navarro-Ocón A., Blaya-Cánovas J.L., López-Tejada A., Blancas I., Sánchez-Martín R.M., Garrido M.J., Griñán-Lisón C., Calahorra J., Cara F.E., Ruiz-Cabello F., Marchal J.A., Aptsiauri N., Granados-Principal S.. Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer. Pharmaceutics. March 2022. DOI: 10.3390/pharmaceutics14030505.
Impacto: 5.4. Cuartil: Q1
Razola-Díaz M.D.C., Gómez-Caravaca A.M., de Andrés J.L., Voltes-Martínez A., Zamora A., Pérez-Molina G.M., Castro D.J., Marchal J.A., Verardo V.. Evaluation of Phenolic Compounds and Pigments Content in Yellow Bell Pepper Wastes. Antioxidants. March 2022. DOI: 10.3390/antiox11030557.
Impacto: 7.0. Cuartil: Q1
(1er decil)
Paco-Meza L.M., Carmona M., Cañadillas S., Lopez-Diaz A., Muñoz-López F., Jimenez-Arranz A., Guler I., Herrera C.. Identification of molecular pathways and protein-protein interactions in adipose tissue-derived mesenchymal stromal cells (ASCs) under physiological oxygen concentration in a diabetic rat model. Iranian Journal of Basic Medical Sciences. February 2022. DOI: 10.22038/IJBMS.2022.59004.13107.
Impacto: 2.2. Cuartil: Q4
Guerrero-Orriach J.L., Carmona-Luque M.D., Gonzalez-Alvarez L.. Heart Failure after Cardiac Surgery: The Role of Halogenated Agents, Myocardial Conditioning and Oxidative Stress. International Journal of Molecular Sciences. February-1 2022. DOI: 10.3390/ijms23031360.
Impacto: 5.6. Cuartil: Q1
Carmona M.D., Paco-Meza L.M., Ortega R., Cañadillas S., Caballero-Villarraso J., Blanco A., Herrera C.. Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy. Pathology Research and Practice. February 2022. DOI: 10.1016/j.prp.2021.153756.
Impacto: 2.8. Cuartil: Q2
Acebedo-Martínez F.J., Voltes-Martínez A., López Ruiz E., Choquesillo-Lazarte D., Fernández-Sánchez J.F., Marchal J.A., Gómez-Morales J.. Apatite-Graphene and Apatite-Graphene Oxide Nanocomposites: Hybrid Materials with Tailored Biological and Luminescent Properties. Solid State Phenomena. 2022. DOI: 10.4028/p-bc0q6b.
Idoia P.C., Raquel F.P., Ismael R.C., Alicia D.M., Elena L.R., Jorge F.F.S., Duane C.L., Juan Antonio M., Jaime G.M.. Type I Collagen-Apatite Fibrillar Nanocomposites: Mineralization, Crosslinking and Anti-Inflammatory Cocrystal Impregnation for Bone Tissue Engineering. Solid State Phenomena. 2022. DOI: 10.4028/p-e1jhe2.
Aguilera-Garrido A., Arranz E., Gálvez-Ruiz M.J., Marchal J.A., Galisteo-González F., Giblin L.. Solid lipid nanoparticles to improve bioaccessibility and permeability of orally administered maslinic acid. Drug Delivery. 2022. DOI: 10.1080/10717544.2022.2086937.
Impacto: 6.0. Cuartil: Q1
Hernández L.G., Alcalá G.R., Carrillo E., Marchal J.A., García M.Á.. The p38 MAPK Components and Modulators as Biomarkers and Molecular Targets in Cancer. International Journal of Molecular Sciences. January-1 2022. DOI: 10.3390/ijms23010370.
Impacto: 5.6. Cuartil: Q1
García-Hernández L., García-Ortega M.B., Ruiz-Alcalá G., Carrillo E., Marchal J.A., García M.Á.. The p38 MAPK Components and Modulators as Biomarkers and Molecular Targets in Cancer. International journal of molecular sciences. 29 December 2021. DOI: 10.3390/ijms23010370.
Impacto: 6.208. Cuartil: Q1
Hernández-Camarero P., López-Ruiz E., Marchal J.A., Perán M.. Cancer: a mirrored room between tumor bulk and tumor microenvironment. Journal of Experimental and Clinical Cancer Research. December 2021. DOI: 10.1186/s13046-021-02022-5.
Impacto: 12.658. Cuartil: Q1
(1er decil)
Sahebi F., Eikema D.J., Koster L., Kroger N., Meijer E., van Doesum J.A., Rovira M., Koc Y., Angelucci E., Blaise D., Sammassimo S., McDonald A., Arroyo C.H., Sanchez J.F., Forcade E., Castagna L., Stölzel F., Sanz J., Tischer J., Ciceri F., Valcarcel D., Proia A., Hayden P.J., Beksac M., Yakoub-Agha I., Schönland S.. Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation: F. Sahebi et al. Transplantation and Cellular Therapy. December 2021. DOI: 10.1016/j.jtct.2021.09.008.
Impacto: 0.0. Cuartil: N/D
Cortijo-Gutiérrez M., Sánchez-Hernández S., Tristán-Manzano M., Maldonado-Pérez N., Lopez-Onieva L., Real P.J., Herrera C., Marchal J.A., Martin F., Benabdellah K.. Improved functionality of integration-deficient lentiviral vectors (IDLVs) by the inclusion of IS<inf>2</inf> protein docks. Pharmaceutics. August 2021. DOI: 10.3390/pharmaceutics13081217.
Impacto: 6.525. Cuartil: Q1
Rosell-Valle C., Antúnez C., Campos F., Gallot N., García-Arranz M., García-Olmo D., Gutierrez R., Hernán R., Herrera C., Jiménez R., Leyva-Fernández L., Maldonado-Sanchez R., Muñoz-Fernández R., Nogueras S., Ortiz L., Piudo I., Ranchal I., Rodríguez-Acosta A., Segovia C., Fernández-Muñoz B.. Evaluation of the effectiveness of a new cryopreservation system based on a two-compartment vial for the cryopreservation of cell therapy products. Cytotherapy. August 2021. DOI: 10.1016/j.jcyt.2020.12.004.
Impacto: 6.196. Cuartil: Q1